Search research articles
Contact Us
Filters
Showing results (1-10 of 115) with videos related to
Page
of 12
Sort By:
Cancer Research
|
January 4, 2019
Type I Protein Arginine Methyltransferases Overexpression Promotes Transformation and Potentiates Her2/Neu-Driven Tumorigenesis
Zachary L Watson, Benjamin G Bitler
Recent Patents on Anti-Cancer Drug Discovery
|
December 8, 2009
Anti-cancer therapies that utilize cell penetrating peptides
Benjamin G Bitler, Joyce A Schroeder
Stem Cell Investigation
|
September 2, 2016
Arid1a controls tissue regeneration
Shuai Wu, Rugang Zhang, Benjamin G Bitler
Science Advances
|
June 5, 2021
Decoding the dynamic tumor microenvironment
Aaron Clauset, Kian Behbakht, Benjamin G Bitler
Plos Genetics
|
October 20, 2023
SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data
Souvik Seal, Benjamin G Bitler, Debashis Ghosh
Expert Opinion on Therapeutic Targets
|
July 1, 2015
Potential therapeutic targets in ARID1A-mutated cancers
Benjamin G Bitler, Nail Fatkhutdinov, Rugang Zhang
DNA Repair
|
July 25, 2025
Multiple functions of PARP1 in the repair of DNA double strand breaks
Raquel Ortega, Benjamin G Bitler, Nausica Arnoult
Expert Review of Precision Medicine and Drug Development
|
December 8, 2018
Epigenetic inhibitors for the precision treatment of <i>ARID1A</i>-mutant ovarian cancers: what are the next steps?
Takeshi Fukumoto, Rugang Zhang, Benjamin G Bitler
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data
Souvik Seal, Benjamin G Bitler, Debashis Ghosh
Molecular & Cellular Oncology
|
June 17, 2016
Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations
Benjamin G Bitler, Katherine M Aird, Rugang Zhang
Page
of 12
Search research articles
Search
Showing results (1-10 of 115) with videos related to
Sort By:
Page
of 12
Cancer Research
|
January 4, 2019
Type I Protein Arginine Methyltransferases Overexpression Promotes Transformation and Potentiates Her2/Neu-Driven Tumorigenesis
Zachary L Watson, Benjamin G Bitler
Recent Patents on Anti-Cancer Drug Discovery
|
December 8, 2009
Anti-cancer therapies that utilize cell penetrating peptides
Benjamin G Bitler, Joyce A Schroeder
Stem Cell Investigation
|
September 2, 2016
Arid1a controls tissue regeneration
Shuai Wu, Rugang Zhang, Benjamin G Bitler
Science Advances
|
June 5, 2021
Decoding the dynamic tumor microenvironment
Aaron Clauset, Kian Behbakht, Benjamin G Bitler
Plos Genetics
|
October 20, 2023
SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data
Souvik Seal, Benjamin G Bitler, Debashis Ghosh
Expert Opinion on Therapeutic Targets
|
July 1, 2015
Potential therapeutic targets in ARID1A-mutated cancers
Benjamin G Bitler, Nail Fatkhutdinov, Rugang Zhang
DNA Repair
|
July 25, 2025
Multiple functions of PARP1 in the repair of DNA double strand breaks
Raquel Ortega, Benjamin G Bitler, Nausica Arnoult
Expert Review of Precision Medicine and Drug Development
|
December 8, 2018
Epigenetic inhibitors for the precision treatment of <i>ARID1A</i>-mutant ovarian cancers: what are the next steps?
Takeshi Fukumoto, Rugang Zhang, Benjamin G Bitler
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data
Souvik Seal, Benjamin G Bitler, Debashis Ghosh
Molecular & Cellular Oncology
|
June 17, 2016
Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations
Benjamin G Bitler, Katherine M Aird, Rugang Zhang
Page
of 12